Selected PUBLICATIONS
Stauffer CS, Morrison TE, Meinzer NK, Leung D, Buffington J, Sheh EG, Neylan TC, et al. (2022) Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial. Psychiatry Research. 308:114340. https://doi.org/10.1016/j.psychres.2021.114340.
Stauffer CS, Samson S, Hickok A, Hoffman WF, Batki SL. (2021) Intranasal oxytocin for stimulant use disorder among male Veterans enrolled in an opioid treatment program: A randomized controlled trial. Frontiers in Psychiatry. 12:804997. doi: 10.3389/fpsyt.2021.804997.
Thorson KR, McKernan SM, West TV, Woolley JD, Mendes WB, Stauffer CS. (2021). Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial. Scientific Reports. 11:21004. https://doi.org/10.1038/s41598-021-99957-8.
Stauffer CS, Anderson BT, Ortigo KM, Woolley J. (2020). Psilocybin-assisted group therapy and attachment: Observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience. ACS Pharmacology & Translational Science. http://dx.doi.org/10.1021/acsptsci.0c00169.
Anderson BT, Danforth A, Daroff R, Stauffer CS, Ekman E, Agin-Liebes G, Trope A, et al. (2020). Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. EClinicalMedicine. 100538.
Stauffer CS, Moschetto JM, McKernan S, Meinzer NK, Chiang C, Rapier R, Hsiang E, et al. (2020). Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial. Journal of Substance Abuse Treatment. 108059.
Stauffer CS, Meinzer NK, Morrison T, Wen J-H, Radanovich L, Leung D, Niles A, et al. (2019). Effects of oxytocin administration on cue-induced craving in co-occurring alcohol use disorder and PTSD: a within-participant randomized clinical trial. Alcoholism: Clinical and Experimental Research. 43(12):2627-2636. PMID: 31610033.
Rapier R, McKernan SM, Stauffer CS. (2019). The inverse relationship between perceived social support and addiction severity. Addictive Behaviors. 10:100188. PMID: 31294075
Trope A, Anderson BT, Hooker AR, Glick G, Stauffer CS, Woolley JD. (2019). Psychedelic-assisted group therapy: A systematic review. Journal of Psychoactive Drugs. 51(2):174-188. PMID: 30950777.
Stauffer CS, Dobberteen L, Woolley JD. (2017). American Alcohol Photo Stimuli (AAPS): A standardized set of alcohol and matched non-alcohol images. The American Journal of Drug and Alcohol Abuse. 43(6):647-655. PMID: 27893279.
Stauffer CS, Musinipally V, Suen A, Lynch KL, Shapiro B, Woolley JD. (2016). A two-week pilot study of intranasal oxytocin for cocaine dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addiction Research and Theory. 24(6):480-498. PMID: 28503120.
Stauffer CS & Woolley JD. (2014). Can we bottle psychosocial treatments for addiction? The role of oxytocin. J Clin Psychiatry. 75(9):1028-9. PMID: 25295428.
A complete list of of publications and other research is available at the links below:
Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022) Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology. https://doi.org/10.1007/s00213-022-06083-y.